During an immune response, antigen-specific T cells undergo massive clonal expansion, contribute to antigen clearance and then generate a memory population capable of more rapid and efficient recall responses. An important feature of memory T cells is their altered trafficking ability, which allows them (but not naive T cells) to survey nonlymphoid tissues (NLTs) 1,2 . It has become clear that a subset of memory CD8 + T cells, resident memory T cells (T RM cells), do not recirculate through the body but are instead maintained in diverse NLTs (including the small intestine, brain, salivary glands, skin and female reproductive tract) [3] [4] [5] [6] [7] [8] [9] . T RM cells have been shown to provide better protection than circulating memory cells do against local secondary infections 5-10 , and T RM cells are now recognized as critical sentinels for protective immunity [11] [12] [13] [14] [15] .
During an immune response, antigen-specific T cells undergo massive clonal expansion, contribute to antigen clearance and then generate a memory population capable of more rapid and efficient recall responses. An important feature of memory T cells is their altered trafficking ability, which allows them (but not naive T cells) to survey nonlymphoid tissues (NLTs) 1, 2 . It has become clear that a subset of memory CD8 + T cells, resident memory T cells (T RM cells), do not recirculate through the body but are instead maintained in diverse NLTs (including the small intestine, brain, salivary glands, skin and female reproductive tract) [3] [4] [5] [6] [7] [8] [9] . T RM cells have been shown to provide better protection than circulating memory cells do against local secondary infections [5] [6] [7] [8] [9] [10] , and T RM cells are now recognized as critical sentinels for protective immunity [11] [12] [13] [14] [15] .
However, an essential and unresolved question is the mechanism through which the residency of T RM cells becomes established [11] [12] [13] [14] . For some NLTs, the expression of integrin α E β 7 (CD103) or its ligand, E-cadherin, by T RM cells contributes to the maintenance of this population 5, 16 . However, those molecules are not expressed by T RM cells in all NLTs 5, 16 , which suggests that such interactions do not constitute a universal mechanism for the retention of T RM cells. Indeed, while CD103 is required for the maintenance of T RM cells in the population of intraepithelial lymphocytes in the small intestine, it is dispensable for the establishment of memory cells in the population of lamina propria lymphocytes of the same organ 16 .
A more consistent marker for T RM cell populations from various NLTs is CD69 expression 13, 16 . Upregulation of CD69 expression is often correlated with stimulation via the T cell antigen receptor (TCR), yet the persistence of foreign antigen is dispensable for the establishment and/or maintenance of T RM cells in various NLTs 8, 16 . Hence, the factors that promote the residency of T RM cells remain ill defined, and nothing is known about the transcriptional regulation that distinguishes cells committing to recirculating populations from those committing to resident populations.
The zinc-finger transcription factor KLF2 directly promotes expression of the genes encoding S1P 1 (the receptor for sphingosine 1-phosphate (S1P)) and L-selectin (CD62L), two molecules that are critical for naive T cell recirculation 17, 18 . S1P 1 , through the detection of its ligand S1P in the blood and lymph, is essential for naive lymphocytes to access the circulatory system from the thymus and lymph nodes 19 . Consequently, deficiency in KLF2 (ref. 17) or S1P 1 (ref. 19 ) results in the retention of naive T cells in lymphoid tissues. Stimulation of the TCR induces rapid loss of KLF2 (and S1P 1 ), which provides a mechanism for the initial retention of activated T cells in lymphoid tissues, whereas these molecules are re-expressed in memory CD8 + T cells isolated from lymphoid tissues [19] [20] [21] [22] . However, potential heterogeneity in the expression of KLF2 and S1P 1 by distinct memory T cell subsets (including T RM cells) has not been investigated. In this study, we found that CD8 + T RM cells in NLTs were characterized by low expression of KLF2 and S1P 1 and that transcriptional downregulation of S1P 1 expression was critical for the establishment of this resident memory pool.
RESULTS

Downregulation of KLF2 expression in CD8 + T cells in NLTs
Although KLF2 is expressed in bulk populations of naive and memory CD8 + T cells 20, 21 , it has remained unclear whether distinct memory subsets differ in KLF2 expression. To investigate this, we used mice 1 2 8 6 VOLUME 14 NUMBER 12 DECEMBER 2013 nature immunology A r t i c l e s with sequence encoding green fluorescent protein (GFP) knocked into the endogenous Klf2 gene, which produces a functional KLF2-GFP fusion protein as a reporter for KLF2 expression 23 . We observed a similar abundance of KLF2-GFP expression in bulk splenic CD62L + (central memory) and CD62L -(effector memory) CD8 + T cells with a memory phenotype (Fig. 1a) . Thus, despite the fact that KLF2 promotes transcription of Sell (which encodes CD62L) 17, 18 , KLF2 expression alone could not be used for accurate prediction of active Sell transcription. We also crossed mice expressing KLF2-GFP with P14 mice (which have transgenic expression of a TCR that recognizes the H-2D b -restricted gp33 epitope derived from lymphocytic choriomeningitis virus (LCMV) glycoprotein (amino acids 33-41; KAVYNFATC)). We adoptively transferred KLF2-GFP P14 CD8 + T cells into nontransgenic C57BL/6 host mice and primed the cells by infecting the host mice with LCMV, Armstrong strain; we also infected unmanipulated KLF2-GFP mice with LCMV in parallel. At the memory stage, both KLF2-GFP P14 CD8 + T cells and polyclonal KLF2-GFP CD8 + T cells that bound the gp33 tetramer had uniformly high KLF2 expression in the spleen and lymph nodes (Fig. 1b) . In contrast, however, memory cells isolated from the small intestine intraepithelium (IELs) and small intestine lamina propria (LPLs) had low KLF2 expression (Fig. 1b) . These findings complemented published findings about gut mucosal T cells of undefined specificity and activation status in unimmunized mice 24 .
We extended the analysis reported above to other NLTs, assaying KLF2-GFP P14 memory CD8 + T cells from the salivary glands, kidneys and brain. Since contamination by blood lymphocytes can complicate the identification of cells in the parenchyma of certain tissues 25 , we intravenously administered antibody to CD8 (anti-CD8) to label (and exclude) cells associated with the vasculature before tissue isolation. Parenchymal KLF2-GFP P14 T cells in salivary glands, kidneys and brains of mice infected with LCMV 8 or 30 d earlier showed downregulation of KLF2 expression, while cells in the lymph nodes and blood, as well as NLT cells associated with the vasculature, had abundant KLF2-GFP expression ( Fig. 1c and  Supplementary Fig. 1a ). CD69 expression was evident for parenchymal T cells in NLTs (Supplementary Fig. 1b) , consistent with the typical T RM cell phenotype [3] [4] [5] 26 . Accordingly, expression of CD69 and KLF2 showed a tight inverse relationship (Fig. 1d) .
Low KLF2-GFP expression might arise from induced degradation of KLF2 protein 21, 27 , yet real-time RT-PCR analysis showed significantly less Klf2 mRNA expression in antigen-primed memory P14 CD8 + Figure 1 Differences in the expression of KLF2 and S1P 1 by memory CD8 + T cells in lymphoid tissues and NLTs. (a) Expression of CD62L and KLF2-GFP (right) in splenic memory-phenotype CD44 hi CD8 + T cells (gated at left). Number adjacent to outlined area (left) indicates percent CD44 hi CD8 + cells; numbers in quadrants (right) indicate percent cells in each throughout. (b) Expression of KLF2-GFP in antigen-specific polyclonal KLF2-GFP CD8 + T cells that bind gp33 tetramer (left; black lines) or adoptively transferred P14 CD8 + T cells (right; black lines), as well as matched wild-type KLF2 CD8 + T cells (background control; gray shaded curves), isolated from the spleen (SPL), lymph nodes (LN), small intestine intraepithelium (IE) and small intestine lamina propria (LP) (above plots) >28 d after infection with LCMV. (c) KLF2-GFP expression (right) by KLF2-GFP P14 CD8 + T cells in the tissue parenchyma (solid lines) or associated with the vasculature (dashed lines) or by P14 CD8 + T cells (control; gray shaded curves) after adoptive transfer into congenic hosts subsequently infected with LCMV (and given intravenous injection of anti-CD8 (CD8β IV) to label vasculature-associated cells), assessed >28 d after infection. Left, gating strategy; numbers adjacent to outlined areas indicate percent vasculature-associated cells (top) or parenchyma cells (bottom). SG, salivary gland. (d) Expression of CD69 and KLF2-GFP by parenchymal P14 T cells in kidneys, salivary glands and blood. (e) RT-PCR analysis of RNA from sorted P14 CD8 + T cells isolated from the spleen, salivary glands or small intestine lamina propria of mice 30 d after adoptive transfer of P14 T cells and infection with LCMV; results were normalized to those of the spleen and are presented relative to expression of the control gene Hprt. (f) RT-PCR analysis of RNA from activated P14 CD8 + T cells transduced with retroviral vector encoding KLF2 or empty vector (EV), followed (2 d later) by enrichment for cells expressing the transduction marker Thy-1.1; results were normalized to those of cells transduced with empty vector and are presented relative to expression of Hprt. Inset, surface expression of CD69 on transduced Thy-1.1 + cells. NS, not significant (P > 0.05); *P < 0.05, **P < 0.01 and ***P < 0.001 (one-way analysis of variance (e,f) with Dunnett's multiple-comparison test (e)). Data are representative of three independent experiments with nine mice (a,c,d) or at least three independent experiments with six to twelve mice (b) or are from four independent experiments with results pooled from nine to twelve mice in each (e; mean and s.d.) or three independent experiments (f). npg T cells sorted from NLTs (small intestine lamina propria and salivary gland) than in their counterparts from the spleen (Fig. 1e) . Furthermore, expression of the KLF2 targets S1pr1 and Sell was also much lower in the NLT populations than in their counterparts in the spleen (Fig. 1e) . The detection of S1P 1 expression on the surface of CD8 + T cells is difficult with the reagents available at present, which precluded accurate comparison between tissues (data not shown). However, published studies have shown that S1P 1 deficiency leads to cell-surface expression of CD69 (due to the loss of competitive protein-protein interactions between CD69 and S1P 1 ) 28, 29 ; hence, our finding that T RM cells were uniformly CD69 + might have been a consequence of lower S1pr1 expression. Indeed, despite substantial differences in the abundance of CD69 at the cell surface ( Supplementary Fig. 1b) , the abundance of Cd69 transcripts was not significantly different among memory P14 cells from the spleen, salivary glands and small intestine lamina propria (Fig. 1e) , although there was a trend toward moderately higher expression of Cd69 mRNA in cells from the small intestine lamina propria. To further explore how KLF2 influences CD69 expression, we evaluated the effect of forced KLF2 expression by activating P14 CD8 + T cells in vitro with anti-CD3 and anti-CD28 or stimulating them with gp33 peptide, and transducing them with a retroviral vector encoding mouse KLF2 or a control ('empty') vector). As anticipated 17, 18 , ectopic KLF2 expression increased the abundance of S1pr1 mRNA and Sell mRNA but not Cd8a mRNA (Fig. 1f) . Forced KLF2 expression also caused a slightly greater abundance of Cd69 mRNA, in contrast to the reduction in cellsurface expression of CD69 protein (Fig. 1f) . These findings showed that KLF2 did not repress Cd69 transcription and supported a model in which elevated surface expression of CD69 protein in KLF2 lo cells is a consequence of lower S1P 1 expression. Together our data suggested that T RM cells in NLTs were distinguished from their recirculating counterparts by low expression of KLF2 and its transcriptional targets, including S1pr1.
Loss of KLF2 expression in T RM cells KLF2 expression is reduced after activation via the TCR, but KLF2 is re-expressed in the effector phase of the T cell response 20, 21 , which is the same stage at which antigen-specific CD8 + T cells become established in NLTs [11] [12] [13] [14] 30 . Hence, it was important to define the kinetics of changes in KLF2 expression in T cells during the immune response. We transferred congenically distinct KLF2-GFP P14 CD8 + T cells and P14 CD8 + T cells expressing wild-type KLF2 together into recipient mice and analyzed the cells throughout the effector and memory response elicited by LCMV infection. KLF2 expression dropped precipitously in responding P14 cells by 48 h after infection (Fig. 2a) , but in lymphoid tissues and blood, KLF2 expression was fully recovered by 5 d after infection and was maintained into the memory phase (Fig. 2b,c) . In contrast, P14 cells from the parenchyma of NLTs showed variable KLF2 expression at day 5 after infection but were KLF2 lo in all NLTs from 8 d after infection onward (Fig. 2b,c and Supplementary Fig. 2 ). That time frame was synchronous with the establishment of T RM cells, as shown by the peak in the accumulation of P14 cells in lymphoid tissues and NLTs (Fig. 2d) . Such data were consistent with a model in which CD8 + T cells enter the NLTs (from the blood) as a KLF2 hi population and lose KLF2 expression while establishing the T RM cell pool. KLF2 expression decreased with similar kinetics in CD8 + T cells from all NLTs studied, in contrast to the much greater variability in the upregulation of CD103 expression, which was rapid and prominent in some NLTs but barely detectable in others during this time course 16 (Fig. 2c) . The rapid termination of KLF2 expression in CD8 + T cells while they settled in NLTs, together with the loss of trafficking molecules regulated by KLF2 (Fig. 1e) , suggested that lower KLF2 expression may have been important in the establishment of T RM cells in various sites.
KLF2 expression in T RM cells and recirculating CD8 + T cells Some recirculating memory CD8 + T cells (the classically defined subset of effector memory T cells (T EM cells) 31 ) would be expected to traffic through NLTs, and we sought to analyze KLF2 expression by this population relative to its expression by non-recirculating T RM cells. Hence, we conducted parabiosis experiments. We transferred congenic KLF2-GFP P14 T cells into C57BL/6 mice, which we then A r t i c l e s infected with LCMV; we infected other C57BL/6 mice (without adoptive transfer) with LCMV in parallel. We allowed both groups of mice to 'rest' for at least 30 d to allow immunological memory to form, and then surgically joined pairs of mice from each group, which led to shared circulation and permitted recirculating memory cells access to NLTs 2 ( Supplementary Fig. 3 ).
As expected (on the basis of published studies 2,7,9 ), memory P14 CD8 + T cells were well represented in lymphoid tissues of the parabiont but were scarce in various NLTs (Fig. 3a) . That finding reinforced the concept that most antigen-primed memory CD8 + T cells in nonlymphoid sites were T RM cells, but it also allowed us to investigate the expression of KLF2 and CD69 on the rare population of recirculating effector memory cells that reached the NLT parenchyma. Notably, such cells exhibited intermediate expression of KLF2 and CD69, which differed from the KLF2 lo CD69 hi phenotype of T RM cells (which were prominent in the 'donor' mouse in the parabiotic pair; Fig. 3b-d) . Hence, the small fraction of CD8 + T cells that entered the NLTs from the blood at memory time points (chiefly recirculating T EM cells) had higher KLF2 expression than that of the established T RM population. Such recirculating cells may have corresponded to the small population of KLF2 + memory CD8 + T cells observed within NLTs in the steady state.
Forced expression of S1P 1 inhibits the establishment of T RM cells Although reduced expression of KLF2 (and its targets) correlated with the formation of T RM cells, the mechanistic relevance of these changes was unclear. Of the KLF2 transcriptional targets, S1P 1 was a strong candidate for regulating the retention of T RM cells, given the welldocumented role of S1P 1 in controlling T cell egress 19, 22 . Hence, we explored how forced S1P 1 expression affected the residency of CD8 + T cells in NLTs. We transduced activated P14 CD8 + T cells with retroviral vectors 28, 32 encoding the transduction marker Thy-1.1 alone (empty vector) or S1P 1 and Thy-1.1 (S1P 1 vector) (Supplementary Fig.  4a ) and transferred those cells together into congenic recipient mice that we subsequently infected with LCMV. We verified forced expression of S1P 1 in transduced cells maintained in vitro ( Supplementary  Fig. 4b) . A potential caveat with this approach arises from studies of mice with transgenic expression of S1P 1 indicating that forced expression of S1P 1 impairs the population expansion of T cells after activation via the TCR 33 . However, we did not observe that effect in cultures of retrovirally transduced P14 cells (Supplementary Fig. 4c,d ).
While the frequency of P14 cells transduced with empty vector or S1P 1 vector was similar in lymphoid tissues, the frequency of P14 cells transduced with S1P 1 vector was considerably lower than P14 cells transduced with empty vector in NLTs (Fig. 4a) . We plotted the frequency of P14 cells transduced with empty vector or S1P1 vector in each tissue relative to the frequency in the spleen, to normalize between experiments (Supplementary Fig. 5a ). Transduction with the S1P 1 vector had little effect in lymphoid tissues but profoundly reduced the representation of P14 T cells in NLTs (Fig. 4b) . We observed that result in NLT parenchyma but not the corresponding population associated with the vasculature (Fig. 4c) , which ruled out the possibility that tissue processing had an effect on this result. We observed the lower abundance of P14 cells transduced with S1P 1 vector in NLTs from early time points (3-5 d; Fig. 4d ), which suggested that forced expression of S1P 1 prevented the initial formation, or 'settling' , of the NLT-resident pool. Analysis of the absolute number of transduced P14 cells confirmed that conclusion, with transduction of the S1P 1 vector having a minimal effect on recovery from lymphoid sites, while it led to a substantial reduction in the size of the population isolated from various NLTs ( Supplementary Fig. 5b,c) .
The effect on IELs of forced S1P 1 expression was more variable (albeit still significant; Fig. 4b ) than its effect on populations from other tissues (Supplementary Fig. 6a ). As CD103 is important for the maintenance of T RM cells in the IEL population 16 , we considered whether upregulation of CD103 expression might override S1P 1 in promoting the residency of cells in other NLTs. If this occurred, we might expect to find that the small population of cells transduced with S1P 1 vector that remained in NLTs exhibited faster and/or more efficient induction of CD103 than that of control cells transduced with empty vector. However, the CD103-induction profiles of both groups were similar (Supplementary Fig. 6b) , which challenged this model.
Our conclusions were in contrast to studies suggesting S1P 1 induces tissue residency of T cells 34 . However, that report examined the migration of naive T cells (and chiefly focused on CD4 + T cells) after injection into the footpad, while our studies tracked the physiological trafficking of activated CD8 + T cells during an immune response. Such differences might account for the discrepancy in these findings. S1P 1 is well known for promoting lymphocyte egress 19, 22 , but it was possible that it served to limit entry into NLTs in our studies. To explore this issue, we used a distinct model system that permitted us to more tightly synchronize the entry of CD8 + T cells into NLTs. Skin inflammation induced by DNFB (2,4-dinitro-1-fluorobenzene) leads to the acute recruitment of in vitro-activated effector CD8 + T cells and local generation of T RM cells 8 . Consistent with our data obtained with other NLTs, activated P14 cells present in DNFB-treated skin downregulated KLF2-GFP expression (Fig. 5a) . We next adoptively transferred in vitro-activated P14 cells transduced with the S1P 1 vector or empty vector (and cultured in vitro to allow time for S1P 1 expression) into mice that we subsequently treated with DNFB. Cells transduced with either vector entered DNFB-treated skin in similar numbers at day 2 after transfer ( Fig. 5b) , which suggested no effect of S1P 1 expression on entry into the inflamed site. However, during successive days, the numbers of cells transduced with S1P 1 vector decreased significantly in the skin but not in the spleen (Fig. 5b) . We also observed that effect when we monitored the frequency of transduced cells in spleen and skin (Fig. 5c) . These results were consistent with a model in which forced S1P 1 expression drives egress from the inflamed skin. Together these data suggested that sustained S1P 1 expression was incompatible with formation of the T RM cell population. We extended those studies to assess the effect of forced KLF2 expression on the generation of tissue-resident cells. We transduced activated P14 cells with a retroviral vector encoding KLF2 or a control ('empty') vector and adoptively transferred those cells into mice that we subsequently treated with DNFB. Transduction with the retrovirus encoding KLF2 led to an increase in mRNA encoding S1P 1 (and CD62L) (Fig. 1f) , which suggested we had achieved adequate expression of KLF2 to affect transcription of target genes. Similar to forced S1P 1 expression, ectopic KLF2 expression had no effect on the early accumulation of donor T cells in the inflamed skin (Fig. 5d, day 2) but did lead to a significant decrease in the maintenance of this population at later time points (Fig. 5d, day 8) . While the pleotropic effects of overexpressed KLF2 (ref. 35 ) could complicate interpretation of these experiments, the similar effects of forced expression of S1P 1 or KLF2 supported a model in which reduced expression of KLF2 and a subsequent decrease in S1P 1 are important steps in establishment of the tissue-resident T cell pool.
Loss of KLF2 expression in NLT is not due to TCR engagement
The loss of KLF2 during the generation of T RM cells indicated a basis for impaired S1P 1 expression. However, which signals induced downregulation of KLF2 expression in NLTs remained unknown. Stimulation of the TCR is known to terminate KLF2 expression 21, 27 , and even though our LCMV model system involved acute infection (with the Armstrong strain), it was possible TCR engagement persisted in NLTs.
First, we investigated whether downregulation of KLF2 expression was induced in a situation in which no cognate foreign antigen was present in vivo. We stimulated KLF2-GFP P14 CD8 + T cells with the LCMV gp33 peptide in vitro, cultured the cells for 48 h and then transferred them into uninfected recipient mice. We assessed KLF2-GFP expression 12-15 d later. Although the migration of P14 CD8 + T cells to NLTs was not as robust as that in LCMV-infected hosts (data not shown), we detected similar patterns of KLF2-GFP expression, with cells in lymphoid sites retaining high expression of KLF2, while donor T cells in NLT were KLF2 lo (Fig. 6a) . Together with the downregulation of KLF2 expression on P14 CD8 + T cells migrating into DNFB-treated skin, these data suggested that engagement of the TCR with specific foreign peptides presented by major histocompatibility complex molecules was not required for downregulation of KLF2 expression in the developing T RM cell population. 
It was possible, however, that engagement of the TCR with other cross-reactive foreign antigens (such as those from commensal microbes) or even self peptides associated with major histocompatibility complex molecules might have driven the KLF2 lo phenotype of the T RM cell population. To investigate that hypothesis, we used Nur77-GFP mice, which have transgenic expression of a green fluorescent protein-transcription factor Nur77 fusion that sensitively reports TCR stimulation 36 . Nur77-GFP expression on P14 memory cells in spleen and most NLTs (IELs from the small intestine, salivary glands and kidneys) did not differ from that in naive cells (Fig. 6b) . Systemic immunization with peptide elicited strong induction of Nur77-GFP expression by memory Nur77-GFP P14 CD8 + T cells in NLTs (Fig. 6b) , which suggested the reporter was functional. We did observe modest (yet reproducible) increases in Nur77-GFP expression in cells isolated from the small intestine lamina propria (Fig. 6b) , which echoed the slightly greater abundance of Cd69 transcripts in that population (Fig. 1e) . Hence, with the possible exception of the small intestine lamina propria after infection with LCMV, our data suggested that basal stimulation of TCRs was similar in memory CD8 + T cells from both lymphoid and nonlymphoid sites, which challenged the proposal of engagement of peptide-major histocompatibility complex as a mechanism for the downregulation of KLF2 expression.
Cytokines induce downregulation of KLF2 expression
Cytokines can also induce downregulation of KLF2 expression in activated CD8 + T cells 18, 21, 37 . Studies have demonstrated that tumor growth factor-β (TGF-β) paired with various cytokines induce activated CD8 + T cells to acquire the CD69 hi CD103 + phenotype of resident memory IELs 16 . Hence, we investigated whether those cytokines also regulated KLF2-GFP expression. Using in vivo-activated KLF2-GFP P14 CD8 + T cells, we observed that culture with pairwise combinations of tumor-necrosis factor, interleukin 33 (IL-33) and TGF-β acted together to reduce KLF2-GFP expression, while the addition of all three cytokines led to even more robust loss of KLF2 expression (Fig. 7a,b) . Kinetically, downregulation of KLF2-GFP expression was detectable within the first day of exposure to TGF-β and IL-33 but was more substantial at 40 h (Supplementary Fig. 7a ). TGF-β and IL-6 (a cytokine combination that failed to drive a complete resident memory IEL phenotype 16 ) more modestly reduced the expression of KLF2-GFP (Fig. 7b) . IL-15 is important for the survival of memory CD8 + T cells 38 , and this cytokine induced KLF2 expression in activated CD8 + T cells, as expected 37, 39 (Supplementary Fig. 7b ). However, exposure to IL-15 together with TGF-β and IL-33 led to loss of KLF2 expression (Supplementary Fig. 7b ), which indicated that the downregulation pathway dominated.
IL-12 also elicits loss of KLF2 expression 21 , and various combinations of cytokines have been shown to promote CD69 expression at the cell surface 40 , so we extended our studies to other cytokines. Both type I interferons and IL-12 induced a substantial reduction in KLF2-GFP expression, while IL-18 had a more modest (although still significant) effect (Fig. 7c) . Notably, the combination of IL-12 with IL-18 (a signal that can induce effector functions in natural killer cells and CD8 + memory cells) led to substantial loss of KLF2-GFP expression, similar to the effects of TGF-β and IL-33 (Fig. 7c) . Hence, these data reinforced the concept that multiple combinations of distinct cytokines led to the KLF2 lo phenotype.
Klf2 transcription is induced by the transcription factor Foxo1, and the latter is negatively regulated by signaling via the kinases PI(3)K and Akt 41 . Furthermore, IL-2-induced downregulation of KLF2 expression is dependent on activation of the PI(3)K-Akt pathway 37 . Although TGF-β signals mainly through the signal-transducer Smad pathway, it also activates PI(3)K in some situations 42 . Indeed, we found that the ability of TGF-β and IL-33 to induce loss of KLF2-GFP expression was substantially reversed by blockade of either PI(3)K or Akt ( Fig. 7d and Supplementary Fig. 7c ). We obtained similar results with in vitro-activated P14 CD8 + T cells (Supplementary Fig. 7d ), which minimized concerns that the cytokines (or inhibitors) mediated their effects through other cell types.
To determine the mechanism of cytokine-induced downregulation of KLF2 expression, we did RT-PCR analysis of in vitro-activated cells. These studies revealed that TGF-β and IL-33 induced transcriptional downregulation of Klf2 and the KLF2 targets S1pr1 and Sell but did not reduce transcription of Cd69 or Cd8a (Fig. 7e) . Furthermore, that pattern was reversed by inhibition of Akt (Fig. 7e) . Hence, TGF-β and IL-33, in a manner dependent on PI(3)K-Akt, induced changes in gene expression similar to those observed in T RM cells. Whether those cytokines directly activated PI(3)K-Akt or acted through intermediate factors, however, was not clear. Notably, the induction of CD103 expression by treatment with TGF-β-IL-33 was unaffected by inhibitors of PI(3)K or Akt (Supplementary Fig. 7e ), which suggested that the signaling pathways that control the expression of CD103 and KLF2 are distinct.
We next sought to explore the pathways that regulated KLF2 expression in vivo. Our data showed that various cytokines were able to induce loss of KLF2 expression in activated CD8 + T cells, which made it unlikely that individual cytokines (or pairs of cytokines) would have a nonredundant role in the regulation of KLF2 and thus limited the utility of cytokine blockade or gene-knockout approaches.
However, the finding that PI(3)K signaling seemed to be crucial for cytokine-induced downregulation of KLF2 expression prompted us to determine whether transient inhibition of PI(3)K in vivo would affect the settling of cells in NLTs. We adoptively transferred P14 CD8 + T cells into congenic hosts that we infected with LCMV. We subsequently treated some of the mice for 24 h with the PI(3)K inhibitor LY294002 in vivo and quantified both KLF2-GFP expression and donor T cells in lymphoid and nonlymphoid sites. Notably, blockade of PI(3)K led to a significant decrease in the number of P14 cells in NLTs but not in the spleen (Fig. 7f) . Furthermore, we observed elevated KLF2-GFP expression in P14 cells in several NLTs (Supplementary Fig. 8a ). Such data were consistent with the proposal that the PI(3)K-Akt pathway 
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A r t i c l e s in T cells is important for loss of KLF2 expression and the generation of T RM cells (although interpretation of these studies is complicated by the fact that systemic blockade of PI(3)K will affect diverse cell populations). Finally, PI(3)K-Akt signaling can elicit degradation of Foxo1 protein 43 , and we observed less Foxo1 in memory P14 cells from salivary glands than in those from the spleen ( Supplementary  Fig. 8b ), consistent with induction of this pathway in NLTs in vivo.
DISCUSSION
Overall our data indicated that T RM cells in NLT were characterized by low expression of KLF2 and that this was functionally relevant for establishment and/or retention of the T RM cell pool through transcriptional downregulation of the key KLF2 target S1pr1. In various systems, the migration of CD8 + T cells into NLTs peaks during the effector phase of the immune response, and parabiosis experiments (including those in our study here) suggest that there is minimal replacement of T RM cells by T cells from the circulation at memory time points [11] [12] [13] [14] 30 . Hence, the T RM cell pool is typically seeded early in the immune response. That pattern is consistent with transient expression of key trafficking molecules on effector CD8 + T cells (such as the brief induction of integrin α 4 β 7 required for the generation of CD8 + T RM cells in the small intestine IEL pool 3 ). However, effector cells that enter NLTs are faced with the 'decision' of whether to rejoin the circulation or commit to long-term residency. Our studies have suggested that commitment to the T RM cell subset involved loss of KLF2 expression (and, consequently, S1P 1 expression). Such findings are consistent with a study showing a lower abundance of S1pr1 transcripts in mouse CD8 + T RM cells settling in the skin epidermis during the response to infection with herpes simplex virus 44 . Similar loss of S1PR1 expression has been reported in a study of gene expression in human CD8 + T cells at sites of reactivation of herpes simplex virus type 2 in the skin 45 . Such data support the hypothesis that transcriptional downregulation of S1pr1 is a defining feature of T RM cells in humans as well as mice.
In the acute infection-inflammation systems we explored here, the decrease in KLF2 expression did not correlate with sustained stimulation of the TCR by the T RM cell population. The finding that T RM cells uniformly expressed CD69 (a marker often considered a surrogate for T cell stimulation) is best explained by a decrease in S1P 1 through the well-documented mutual antagonism between CD69 and S1P 1 for cellsurface expression 28, 29 . However, in situations of persistent local infection, such as infection of the brain with vesicular stomatitis virus 4 or infection of mouse skin with herpes simplex virus type 1 (ref. 6), the T RM cell population may also undergo recurrent activation of the TCR. Such stimulation would also drive loss of KLF2 expression as well as upregulate the transcription of Cd69 (further compromising S1P 1 expression). Thus, persistence of foreign antigen may reinforce the mechanisms for dampening effective S1P 1 expression by the T RM cell subset.
Our studies focused on establishment of the T RM cell pool and have demonstrated that sustained S1P 1 expression was incompatible with the generation of this population. Other molecules may further 'anchor' T RM cells in NLTs. A good candidate is CD103, whose expression is upregulated in many (but not all) nonlymphoid sites. Notably, deficiency in CD103 does not compromise the initial settling of activated CD8 + T cells into the small intestine IEL population (in contrast to the effect of forced S1P 1 expression reported here) but does lead to a decrease in the small intestine intraepithelial population (but not small intestine lamina propria population) at later time points 16 . Hence, in at least some tissues, CD103 expression may provide an important long-term retention signal. However, our studies suggest that control of S1P 1 expression is a necessary prelude to this step.
NLTs are not exclusively populated by T RM cells; our parabiosis studies confirmed that a small subset of recirculating T EM cells entered the nonlymphoid sites from the blood. Notably, these cells had intermediate expression of KLF2 and CD69. Whether that phenotype indicated that such cells were in the process of joining the T RM cell pool or instead indicated a transient decrease in KLF2 expression by cells destined to rejoin the circulation (as part of the classic recirculating T EM cell pool) is not clear. Studies examining extended parabiosis periods have reported that recirculating cells continue to constitute a small fraction of the NLT parenchymal population 2, 7 , indicative of minimal replacement of T RM cells over time. In any case, our data indicated that the KLF2 lo phenotype marked cells that did not themselves recirculate and hence corresponded to the T RM cell population.
Other factors beyond expression of KLF2 and S1P 1 may support recirculation. For example, CCR7 expression has been shown to promote the egress of lymphocytes from NLTs 46, 47 . Nevertheless, the presence of an abundant population of CCR7 lo T EM cells in the blood and spleen indicates that this expression pattern alone does not lead to the retention of cells in nonlymphoid sites. In contrast, we found that most T EM cells in lymphoid tissues were KLF2 hi , while most T RM cells were KLF2 lo ; hence, the KLF2 lo phenotype was more reliable than the CCR7 lo phenotype in allowing prediction of resident versus recirculating properties of memory CD8 + T cells.
We found that various cytokines were able to promote downregulation of KLF2 expression. We especially focused on tumor-necrosis factor, IL-33 and TGF-β, as they have been shown to promote other phenotypic traits of T RM cells 16 . However, cytokines may control multiple pathways involved in the establishment of T RM cells. For example, TGF-β promotes not only downregulation of KLF2 expression but also upregulation of CD103 expression. Reactivity to TGF-β is critical for the establishment of T RM cells in the small intestine IEL pool 16 , but defining the relative contributions of the regulation of KLF2 versus that of CD103 is difficult. At a more general level, our data suggest induction of the PI(3)K pathway by these cytokines may be a core element in the control of KLF2 expression. Such findings resonate with studies suggesting that the PI(3)K signaling cascade, while typically considered from the perspective of cell survival and metabolism, has a crucial role in the migration of T cells 48 . Hence, we propose that diverse cytokines (potentially distinct combinations in distinct NLTs) converge on the PI(3)K-Akt pathway as a mechanism for enforcing downregulation of KLF2 expression.
It is already clear that CD8 + T RM cells have a critical role as a first line of defense against local infection [5] [6] [7] [8] [11] [12] [13] [14] . Our data suggest that induced downregulation of the expression of KLF2 or S1P 1 could be used to efficiently populate or enhance the formation of T RM cells during vaccination. Treatments that cause local induction of PI(3)KAkt signaling might be used to enhance establishment of T RM cells in desired sites, potentially in combination with approaches that increase the local recruitment of circulating T cells into NLTs 8, 15 . At the same time, T RM cells may also contribute to pathological conditions, such as fixed drug eruptions in the skin 11, 13 . Hence, our studies indicate potential therapeutic targets through which the generation of resident memory CD8 + T cells could be promoted or reversed. S1P 1 expression is firmly established as being critical for lymphocyte recirculation; our data have indicated that the immune system coopts regulation of that pathway to dictate the residency of T RM cells. Furthermore, our studies indicated that expression of KLF2 constitutes a defining transcription factor of recirculating versus resident memory CD8 + T cells. There has been considerable advancement in relating the functional characteristics of T cell subsets to key transcriptional regulators [49] [50] [51] ; our work has suggested another dimension in this system whereby control of T cell recirculation through regulated KLF2 expression determines the tissue-distribution characteristics of T cell subsets and hence dictates how effector functions are deployed during recall responses.
METHODS
Methods and any associated references are available in the online version of the paper. 
ONLINE METHODS
Mice. C57BL/6 and CD45.1 + congenic B6.SJL mice (from the National Cancer Institute) were used at 6-8 weeks of age. KLF2-GFP and Nur77-GFP reporter mice have been described 22, 34 and were crossed to P14 mice (specific for the H-2D b -restricted LCMV gp33 epitope (KAVYNFATC)). For adoptive cotransfer studies, combinations of CD45.2 + , CD45.1 + and CD45.1 + CD45.2 + mice were used as donor and host strains to allow discrimination of each donor population versus host cells. Animals were maintained under specific pathogen-free conditions at the University of Minnesota. All experimental procedures were approved by the Institutional Animal Care and Use Committee at the University of Minnesota.
Adoptive transfer and infection. Splenocytes were prepared from KLF2-GFP (or Nur77-GFP) P14 mice and congenic P14 mice. The cell populations were mixed at a ratio of 1:1, and 2.5 × 10 4 to 4.5 × 10 4 CD8 + T cells were transferred into congenic recipient mice, which were infected the next day by intraperitoneal injection of 2 × 10 5 plaque-forming units of LCMV (Armstrong strain). Mice were maintained in Biosafety Level 2 housing and, at the appropriate time after infection, were killed for analysis.
In vivo intravenous injection of anti-CD8 and lymphocyte isolation. To label cells in the circulation, mice were given injection of fluorochromeconjugated anti-CD8β (53-5.8; BioLegend or BD Bioscience) via the tail vein, as described 25 . At 2.5 min after injection of the antibody, blood was obtained from mice and, 30 s later, mice were killed. The heart was perfused with 10 ml of cold PBS (in some experiments, this step was eliminated) and tissues were collected and lymphocytes were isolated as described 16, 25 . Lymph nodes were 'mashed' to achieve single-cell suspensions, while the salivary glands, kidneys, brain and spleen were 'mashed' and then incubated at 37 °C in a solution of RPMI medium containing 100 U/ml collagenase type I (Worthington Biochemical), 10% FBS, MgCl 2 -CaCl 2 , HEPES, pH 7.2, and l-glutamine, with mixing (45 min of shaking in spinner plates, with magnetic stirrers rotating at 450 r.p.m.). Skin tissues were minced and then incubated for 90 min at 37 °C in RPMI medium with 2% FCS and collagenase D (1 mg/ml; Roche Applied Science) and DNase I (5 µg/ml; Sigma). For the small intestine, Peyer's patches were dissected out and the remaining tissue was cut longitudinally and then into pieces 1 cm in length. Those were rinsed and then were incubated for 30 min at 37 °C (in spinner plates, as described above) with 15.4 mg/ml dithiothreitol in Hank's balanced-salt solution and HEPES, pH 7.2, bicarbonate buffer, for extraction of IELs. The remaining pieces were additionally incubated with the collagenase solution and conditions described above, for isolation of LPLs. All tissues were then fractionated by centrifugation for 20 min at 21 °C through a 44%-67% Percoll gradient (858g) for isolation of lymphocytes.
Flow cytometry and antibodies. Single-cell suspensions were prepared and cells were resuspended at a density of 3 × 10 7 to 6 × 10 7 cells per ml in flow cytometry buffer (1% FBS and 0.1% sodium azide in PBS) and were stained in a volume of 100 µl. Isolated lymphocytes in all experiments were incubated for 15 min at 4 °C with LIVE/DEAD Fixable Aqua Dead Cell Stain Kit (Invitrogen) for the detection of dying cells before being stained with a 'cocktail' of antibodies for staining the cell surface. For detection of Foxo1, lymphocytes were isolated from the salivary glands and spleens of C57BL/6 mice 30-60 d after adoptive transfer of P14 CD8 + T cells and infection with LCMV. After surface staining, cells were fixed for 45 min at 4 °C in Intracellular Fixation and Permeabilization Buffer (eBioscience). Cells were then stained for 45 min at 4 °C with anti-Foxo1 (c29H4; Cell Signaling) or rabbit IgG isotype-matched control antibody (2729; Cell Signaling) at a dose of 75-150 ng per test. That was followed by incubation for 30 min on ice with the secondary antibody phycoerythrin-conjugated donkey anti-rabbit (111-116-144; Jackson ImmunoResearch). All other fluorochome-conjugated antibodies are identified in Supplementary Table 1. Cells were analyzed with an LSR II (BD Pharmingen) and data were analyzed with FlowJo software (TreeStar).
For analysis of P14 CD8 + T cells in all tissues, the gating strategy included live, singlet CD8 + lymphocytes expressing relevant P14 congenic markers. Association with the vasculature was determined by intravenous staining with anti-CD8β (identified above) 25 , as described above.
Quantitative RT-PCR. Congenically marked P14 cells and KLF2-GFP P14 cells were transferred together into C57BL/6 mice that were infected with LCMV the next day. At 28-36 d after infection with LCMV, the spleen, salivary glands and LPL of the small intestine were isolated and P14 CD8 + T cells were sorted on a FACSAria (Becton Dickinson) on the basis of the congenic markers. In other studies, cells were activated in vitro and were cultured for 40 h with the appropriate cytokines or were transduced with retrovirus expressing KLF2 or control retrovirus, then cultured for 2 d and subjected to magnetic enrichment for cells bearing the transduction marker (Thy-1.1) before analysis. In all cases, RNA was isolated with an RNeasy microkit (Qiagen), followed by reverse transcription (qScript cDNA synthesis kit; Quanta Biosciences). Gene expression was assessed (in triplicate for cultured cells; in duplicate for ex vivo samples) with an ABI 7700 sequence-detection system (primers, Supplementary Table 2 ) and amplification was detected with SYBR Green PCR Master Mix (Applied Biosystems).
Cycling threshold values for the control target gene (Hprt or Gapdh) were subtracted from cycle threshold values for the gene of interest. Next, the mean values (averaged across all repeated experiments) for gene expression of P14 cells in the spleen (Fig. 1) or P14 cells cultured without additional cytokines (Fig. 7) was used for normalization between experiments.
Parabiosis. Congenically marked KLF2-GFP P14 T cells were transferred into C57BL/6 mice. The next day, the mice were infected intraperitoneally with LCMV and, 30-65 days later, mice underwent parabiotic surgery ( Supplementary  Fig. 3 ) as described 2 . Mice were anesthetized with ketamine, flank hair removed with Nair and the skin was cleaned with Betadine. A lateral incision was made on each mouse from the knee to the elbow. Mice were joined with a continuous subcuticular suture on both the dorsal and ventral sides, with mattress and cruciate sutures joining the skin layer. Mattress sutures just under the armpit and knee were made to secure the parabiosed mice together. At 7-9 d after surgery, blood was obtained from mice to ensure equilibration, and at 13-17 d after surgery, tissues were collected from both mice of each pair. P14 memory T cells not associated with the vasculature were quantified in the donor and parabiont (Supplementary Fig. 3) . A minimum threshold of 25 events was applied for calculation of the median fluorescent intensity of KLF2-GFP and CD69 in P14 T cells.
Retroviral construct generation.
For generation of the S1P 1 -expressing retrovirus vector (MiT-S1PR1), a BglII-NotI fragment including Flag-tagged mouse S1P 1 was amplified by PCR from a MSCV-S1PR1-hCD4 vector 27, 28 (a gift from J. Cyster) and was subsequently subcloned into the retroviral vector MSCV-IRES-Thy1.1 (MiT; provided from J. Chen) 17, 18 . A similar construct was generated with cDNA encoding mouse KLF2, amplified by PCR 17 . The plasmid MiT-S1PR1, MiT-KLF2 or MiT (empty vector) was transfected together with the retroviral packaging vector pCL-Eco into 293T human embryonic kidney cells with Lipofectamine 2000 (Life Technology). The 293T line was established from a mycoplasma-free culture but was not routinely assayed for mycoplasma contamination. Supernatants were collected at 48 h after transfection.
Retroviral transduction approaches and calculations. P14 CD8 + T cells were activated either in vivo or in vitro before retroviral transduction. For activation in vivo, P14 mice were infected intravenously with 1 × 10 6 LCMV, Armstrong strain, and splenocytes were harvested as reported before 52 . In vitro activation involved culture of 2 × 10 6 to 3 × 10 6 bulk P14 splenocytes either with plate-bound anti-CD3 (2 µg/ml per well; 145-2C11; eBioscience) and soluble anti-CD28 (0.5 µg/ml per well; 37.51; eBioscience) in a 24-well plate or with 250 nM gp33 peptide. At 24 h after activation, activated splenocytes (3 × 10 6 to 6 × 10 6 per well of a 24-well tissue culture plate) were incubated for 30 min at 37 °C with 10 µg/ml polybrene and 20 ng/ml human IL-2. After centrifugation of the plates (at 411g for 5 min at 21 °C), the culture medium was removed and 1 ml of the supernatant of retroviral vector expressing S1P 1 or KLF2 or empty vector was added to each well, which also contained 10 µg/ml polybrene and 20 ng/ml IL-2. Spin infection (1,141g for 90 min at 21 °C) was followed by incubation for 1 h at 37 °C to allow the cells to 'rest' before in vivo transfer. In some experiments, retronectin was used to enhance transduction efficiency (six-well plates coated with 25 µg/ml retronectin), followed by spin of 4 ml retrovirus onto the plate for 90 min at 4 °C at 2,000g. The viral supernatant npg was aspirated off, and 6 × 10 6 activated P14 splenocytes and 20 ng/ml human IL-2 were added to the plate, followed by incubation for 30 min at 37 °C. The plates were then spun at 600g for 30 min at 21 °C. For adoptive transfer, 2.5 × 10 4 to 5 × 10 4 P14 cells transduced with S1P 1 vector and the same number of congenically distinct P14 cells transduced with empty vector were transferred together into host mice that were infected with LCMV the next day.
At 3-60 d after transfer, mice were given intravenous injection of anti-CD8 (identified above) to label vasculature associated cells (as described above) and lymphocytes were harvested from tissues. The frequency of transduced live P14 cells not associated with the vasculature was calculated on the basis of expression of the Thy-1.1 marker. For normalization, the frequency of transduced P14 CD8 + T cells in a given tissue was normalized to the frequency of transduced cells in the spleen of the same mouse (Supplementary Fig. 5a ).
For characterization of transduction efficiency and for monitoring proliferation after transduction, splenocytes (at a density of 1 × 10 6 cells per well of a 24-well plate, in 2 ml complete medium) were incubated with 10-20 ng/ml human IL-2. Every 2 d, live cells were counted and were re-incubated at the density noted above with new medium containing human IL-2. Transduction efficiency over time was also monitored (through the use of the Thy-1.1 transduction marker). Some experiments included 250 nm gp33 peptide for the first 2 d after transduction, with similar results.
For DNFB model studies, P14 splenocytes (of two different CD45 congenic types) were activated for 24 h d in vitro (with 1 µM gp33 peptide), then were transduced with retroviral vector expressing either S1P 1 or KLF2 or with empty vector (as described above) and then were maintained in vitro for 4-5 d with human IL-2 (20 ng/ml). From these cultures, the frequency of transduced (Thy-1.1 + ) cells was determined and 2 × 10 6 cells Thy-1.1 + cells transduced with retroviral vector expressing S1P 1 or KLF2 were transferred together with an equal number of Thy-1.1 + P14 cells transduced with empty vector into congenically distinct C57BL/6 background hosts (that were subsequently treated with DNFB, as described below).
In all cases, hosts and both donor populations used for cotransfer differed in being CD45.1 + , CD45.2 + or CD45.1 + CD45.2 + (with different combinations in different experiments) to allow the identification of donor populations by CD45-specific antibodies.
